Impact of type of anticoagulant on clinical outcomes in cancer patients who had atrial fibrillation

To date, evidence on optimal anticoagulant options in patients with AF who concurrently have active cancer remains elusive. To describe anticoagulant patterns and clinical outcomes among patients with a concomitant diagnosis of AF and cancer. Data were obtained from the University of Utah and Huntsm...

Descripción completa

Detalles Bibliográficos
Autores principales: Chai-Adisaksopha, Chatree, Watanabe, Alexandre H., Dilokthornsakul, Piyameth, Navaravong, Leenhapong, Witt, Daniel M., Chaiyakunapruk, Nathorn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10325995/
https://www.ncbi.nlm.nih.gov/pubmed/37414965
http://dx.doi.org/10.1038/s41598-023-38071-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10325995/
https://www.ncbi.nlm.nih.gov/pubmed/37414965
http://dx.doi.org/10.1038/s41598-023-38071-3

Ejemplares similares